The FDA has granted Breakthrough Therapy Designation to Bayer’s PI3K inhibitor Aliqopa (copanlisib) for marginal zone lymphoma (MZL) patients who have received two prior therapies. MZL is an ...

A “loving” South Coast mum already sidelined by cancer has been dealt another crushing blow after being involved in a serious ...

To make matters worse, Ms Brown’s laundry list of serious injuries happened in the midst of cancer treatment, where she is battling Non-Hodgkins Lymphoma and Splenic Marginal Zone Lymphoma.